Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Allena Pharmaceuticals, Inc. | 74,000 | reported | 06 Apr 2021 | tx 1+74,000 |
| CHIASMA, INC | 19,612 | reported | 04 Dec 2020 | tx 9+1,061,114−10,000 |
| Aegerion Pharmaceuticals, Inc. | 10,000 | reported | 01 Apr 2015 | tx 36+194,600−272,950 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Apr 2021 | GRANT_AWARD | Allena Pharmaceuticals, Inc. | 74,000 | 0.00 USD | deriv |
| 04 Dec 2020 | EXERCISE | CHIASMA, INC | 10,000 | 2.60 USD | |
| 04 Dec 2020 | EXERCISE | CHIASMA, INC | 10,000 | 0.00 USD | deriv |
| 14 Feb 2020 | GRANT_AWARD | CHIASMA, INC | 150,000 | 0.00 USD | deriv |
| 14 Feb 2019 | GRANT_AWARD | CHIASMA, INC | 186,000 | 0.00 USD | deriv |
| 20 Dec 2018 | PURCHASE | CHIASMA, INC | 9,612 | 2.50 USD | first after silence |
| 23 Feb 2018 | GRANT_AWARD | CHIASMA, INC | 194,183 | 0.00 USD | deriv |
| 23 Feb 2018 | GRANT_AWARD | CHIASMA, INC | 67,967 | 0.00 USD | deriv |
| 25 Oct 2016 | GRANT_AWARD | CHIASMA, INC | 373,352 | 0.00 USD | deriv |
| 10 Feb 2016 | GRANT_AWARD | CHIASMA, INC | 70,000 | 0.00 USD | deriv |
| 01 Apr 2015 | GRANT_AWARD | Aegerion Pharmaceuticals, Inc. | 10,000 | 0.00 USD | deriv |
| 01 Apr 2015 | GRANT_AWARD | Aegerion Pharmaceuticals, Inc. | 40,000 | 0.00 USD | deriv |
| 31 Dec 2014 | GRANT_AWARD | Aegerion Pharmaceuticals, Inc. | 65,000 | 0.00 USD | deriv |
| 19 Aug 2014 | PURCHASE | Aegerion Pharmaceuticals, Inc. | 1,150 | 30.64 USD | first after silence |
| 01 Apr 2014 | GRANT_AWARD | Aegerion Pharmaceuticals, Inc. | 20,000 | 0.00 USD | deriv |
| 04 Mar 2014 | EXERCISE | Aegerion Pharmaceuticals, Inc. | 2,500 | 17.64 USD | |
| 04 Mar 2014 | EXERCISE | Aegerion Pharmaceuticals, Inc. | 2,500 | 0.00 USD | deriv |
| 18 Nov 2013 | GIFT | Aegerion Pharmaceuticals, Inc. | 100 | 0.00 USD | |
| 18 Nov 2013 | GIFT | Aegerion Pharmaceuticals, Inc. | 100 | 0.00 USD | |
| 10 Feb 2014 | SALE | Aegerion Pharmaceuticals, Inc. | 2,814 | 62.94 USD | |
| 10 Feb 2014 | SALE | Aegerion Pharmaceuticals, Inc. | 900 | 63.72 USD | |
| 10 Feb 2014 | EXERCISE | Aegerion Pharmaceuticals, Inc. | 7,500 | 17.64 USD | |
| 10 Feb 2014 | SALE | Aegerion Pharmaceuticals, Inc. | 3,300 | 61.71 USD | |
| 10 Feb 2014 | SALE | Aegerion Pharmaceuticals, Inc. | 486 | 64.69 USD | |
| 10 Feb 2014 | EXERCISE | Aegerion Pharmaceuticals, Inc. | 7,500 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 20 Dec 2018.